Astra and Sanofi's nirsevimab granted accelerated EU assessment
(Alliance News) - AstraZeneca PLC on Thursday said nirsevimab, which is being developed in collaboration with Sanofi SA, has been accepted for accelerated review by the European Medicines Agency. Read More